{
  "url": "https://www.nasdaq.com/article/tocagens-brain-cancer-treatment-fails-latestage-study-20190912-00171",
  "title": "Tocagen's brain cancer treatment fails late-stage study - Nasdaq.com",
  "text": [
    "Sept 12 (Reuters) - Tocagen Inc  said on Thursday its experimental treatment did not prove effective in helping patients with a type of brain cancer to live longer, in a late-stage study.",
    "The California-based company said in the trial its lead product candidate Toca 511 & Toca FC also did not show meaningful superiority in secondary goals compared to standard of care treatment. ",
    "Sept 12 (Reuters) - Tocagen Inc  said on Thursday its experimental treatment did not prove effective in helping patients with a type of brain cancer to live longer, in a late-stage study.",
    "The California-based company said in the trial its lead product candidate Toca 511 & Toca FC also did not show meaningful superiority in secondary goals compared to standard of care treatment. "
  ],
  "published_datetime": "2019-09-12 06:13:00"
}